Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew X Zhu

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Cancer|November 28, 2007
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinomaAndrew X Zhu
BMC Medicine|August 26, 2009
Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?Andrew X Zhu
Chinese Clinical Oncology|April 6, 2015
Current status of hepatocellular carcinoma in the United StatesAndrew X Zhu
The Oncologist|August 2, 2006
Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?Andrew X Zhu
Best Practice & Research. Clinical Gastroenterology|May 13, 2015
Future directions in the treatment of cholangiocarcinomaAndrew X Zhu
Annals of Surgical Oncology|April 21, 2010
Systemic treatment of hepatocellular carcinoma: dawn of a new era?Andrew X Zhu
Clinical Drug Investigation|August 10, 2012
Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practiceAndrew X Zhu
Expert Opinion on Investigational Drugs|April 7, 2010
Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinomaAndrew X Zhu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A review of the management of hepatocellular carcinoma: standard therapy and a look to new targetsAndrew X Zhu
Cancer Investigation|August 7, 2003
Hepatocellular carcinoma: are we making progress?Andrew X Zhu
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Cancer|November 28, 2007
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinomaAndrew X Zhu
BMC Medicine|August 26, 2009
Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?Andrew X Zhu
Chinese Clinical Oncology|April 6, 2015
Current status of hepatocellular carcinoma in the United StatesAndrew X Zhu
The Oncologist|August 2, 2006
Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?Andrew X Zhu
Best Practice & Research. Clinical Gastroenterology|May 13, 2015
Future directions in the treatment of cholangiocarcinomaAndrew X Zhu
Annals of Surgical Oncology|April 21, 2010
Systemic treatment of hepatocellular carcinoma: dawn of a new era?Andrew X Zhu
Clinical Drug Investigation|August 10, 2012
Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practiceAndrew X Zhu
Expert Opinion on Investigational Drugs|April 7, 2010
Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinomaAndrew X Zhu
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A review of the management of hepatocellular carcinoma: standard therapy and a look to new targetsAndrew X Zhu
Cancer Investigation|August 7, 2003
Hepatocellular carcinoma: are we making progress?Andrew X Zhu
Pageof 32